6 reports

Gilead' s product portfolio and pipeline of investigational drugs encompasses treatments for HIV/ AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions.

  • Cystic Fibrosis
  • AbbVie Inc.
  • Allergan plc
  • Pharmaxis Ltd
  • Vertex Pharmaceuticals Incorporated

Gilead' s product portfolio and pipeline of investigational drugs encompasses treatments for HIV/ AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions.

  • Cystic Fibrosis
  • AbbVie Inc.
  • Allergan plc
  • Pharmaxis Ltd
  • Vertex Pharmaceuticals Incorporated

Engages in the development of drugs for HIV/ AIDS, liver diseases, hematology, oncology, cardiovascular, inflammation, respiratory, and other therapies.

  • Cystic Fibrosis
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • Royalty Pharma Acquires Royalties on Cystic Fibrosis Treatments from Cystic Fibrosis Foundation Therapeutics for USD3.3 Billion

The company offers its products in the therapeutic areas of rheumatoid arthritis (RA), chronic kidney disease, Crohn' s disease, diabetes, HIV/ AIDS and others.

  • Cystic Fibrosis
  • United States
  • Company Financials
  • M&A
  • RP Management LLC
  • ROYALTY PHARMA ACQUIRES ROYALTIES ON CYSTIC FIBROSIS TREATMENTS FROM CYSTIC FIBROSIS FOUNDATION THERAPEUTICS FOR USD3.3 BILLION

It offers its approved products in the therapeutic areas of rheumatoid arthritis (RA), Crohn' s disease, diabetes, chronic kidney disease, HIV/ AIDS and others.

  • Cystic Fibrosis
  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States

The prominent features of this report are - ##.

  • Clinical Trial
  • Cystic Fibrosis
  • Therapy
  • World
  • Product Initiative